A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis.

Naser Moghadasi, Abdorreza

Naser Moghadasi, Abdorreza.

Naser Moghadasi A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: abdorrezamoghadasi@gmail.com.

Autoimmun Rev ; 20(5): 102803, 2021 May.

Article in English | MEDLINE | ID: covidwho-1135257

Subject(s)

COVID-19; Multiple Sclerosis; Adult; Female; Humans; Immunosuppressive Agents; Multiple Sclerosis/diagnosis; SARS-CoV-2

Keywords

COVID-19; Immune response; Multiple sclerosis; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Female / Humans Language: English Journal: Autoimmun Rev Journal subject: Allergy and Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google